Traditional drug development and discovery has not kept pace with threats from emerging
and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV …

The first infection case of new coronavirus was reported at the end of 2019 and after then,
the cases are reported in all nations across the world in a very short period. Further, the …

Currently, no approved vaccine is available against the Middle East respiratory syndrome
coronavirus (MERS-CoV), which causes severe respiratory disease. The spike glycoprotein …

Pseudomonas stutzeri phosphite dehydrogenase (PTDH) catalyzes the oxidation of
phosphite to phosphate in the presence of NAD, resulting in the formation of NADH. The …

COVID‐19, which has spread all over the world and was declared as a pandemic, is a new
disease caused by the coronavirus family. There is no medicine yet to prevent or end this …

Breast cancer (Bc a) is the prominent, most commonly detected, and the leading cause of
mortality among women. Estrogen receptor alpha (ERα) is considered an important receptor …

Alzheimer's disease (AD) is the most common neurodegenerative disorder in the world,
affecting an estimated 50 million individuals. The nerve cells become impaired and die due …

The present study attempted to scrutinize the protective effect of the methanolic extract of P.
chaba stem bark against paracetamol-induced hepatotoxicity in Sprague− Dawley rats …

Overexpression of polo-like kinase 1 (PLK1) has been found in many different types of
cancers. With its essential role in cell proliferation, PLK1 has been determined to be a broad …

Introduction Favipiravir is a repurposed drug to treat coronavirus 2019 (COVID-19). Due to a
lack of available real-world data, we assessed its effectiveness and safety in moderately to …